Allen Mooney & Barnes Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Allen Mooney & Barnes Investment Advisors's LLY Position: Q2 2026 in Review
Allen Mooney & Barnes Investment Advisors reduced its Eli Lilly (LLY) stake by 13% in Q2 2026, selling an estimated $743K and leaving 4,815 shares worth $5.78M. The position accounts for 0.88% of the portfolio, ranked #40.
Allen Mooney & Barnes Investment Advisors first reported a position in LLY in Q1 2022 and has held it in 18 quarters since. The position peaked at $6.18M in Q4 2025. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Allen Mooney & Barnes Investment Advisors held 4,815 shares of Eli Lilly worth $5.78M as of Q2 2026.
- Allen Mooney & Barnes Investment Advisors sold 727 Eli Lilly shares in Q2 2026, an estimated $743K.
- Eli Lilly made up 0.88% of Allen Mooney & Barnes Investment Advisors's portfolio in Q2 2026, its #40 holding.
- Allen Mooney & Barnes Investment Advisors first reported a position in Eli Lilly in Q1 2022 and has held it in 18 quarters since.
- Allen Mooney & Barnes Investment Advisors's Eli Lilly position peaked at $6.18M in Q4 2025.
- 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Allen Mooney & Barnes Investment Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.